What is the difference between Sacubitril And Valsartan and Telmisartan And Amlodipine?

Sacubitril And Valsartan and Telmisartan And Amlodipine are both ARBs, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Sacubitril And Valsartan and Telmisartan And Amlodipine be used for the same conditions?

Both medications are prescribed for overlapping indications including 1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril and a neprilisin inhibitor. Always verify with your prescriber and the current FDA label before switching.

Is Sacubitril And Valsartan the same as Telmisartan and Amlodipine?

No. Sacubitril And Valsartan (Sacubitril And Valsartan) and Telmisartan and Amlodipine (Telmisartan And Amlodipine) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Sacubitril And Valsartan or Telmisartan And Amlodipine?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Sacubitril And Valsartan to Telmisartan And Amlodipine?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Sacubitril And Valsartan vs Telmisartan And Amlodipine

Compare Sacubitril And Valsartan (ARB) and Telmisartan And Amlodipine (Telmisartan and Amlodipine), clinical data, side effects, and patient experiences.

Sacubitril And Valsartan

· ARB

How it works

12.1 Mechanism of Action ENTRESTO contains a neprilysin inhibitor, sacubitril, and an angiotensin receptor blocker, valsartan. ENTRESTO inhibits neprilysin (neutral endopeptidase; ...

Approved for

1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril

a neprilisin inhibitor

and valsartan

an angiotensin II receptor blocker

OralTablet

Telmisartan And Amlodipine

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

Sacubitril And ValsartanTelmisartan And Amlodipine

Drug Class

ARB

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Sacubitril And Valsartan

Low Blood Pressure

>10%

Shortness of Breath

1-10%

Fatigue

1-10%

Cough

1-10%

Weight Loss

1-10%

General Unwellness

0.1-1%

Weight Gain

0.1-1%

Dizziness

1-10%

Telmisartan And Amlodipine

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

Sacubitril And Valsartan

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of angioedema and hypotension
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
However, if there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system, and if the drug is considered lifesaving for the mother, advise a pregnant woman of the potential risk to the fetus [see Use in Specific Populations (8
Angioedema associated with laryngeal edema may be fatal

Telmisartan And Amlodipine

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

Clinical Trial Data

No head-to-head clinical studies found for Sacubitril And Valsartan vs Telmisartan And Amlodipine.

Sacubitril And Valsartan vs Telmisartan And Amlodipine: What You Should Know

Key Differences

Both Sacubitril And Valsartan and Telmisartan And Amlodipine belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Sacubitril And Valsartan carries 4 FDA warnings. Telmisartan And Amlodipine carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Sacubitril And Valsartan vs Valsartan→Irbesartan vs Sacubitril And Valsartan→Sacubitril And Valsartan vs Valsartan And Hydrochlorothiazide→Sacubitril And Valsartan vs Telmisartan→Sacubitril And Valsartan vs Telmisartan And Hydrochlorothiazide→Irbesartan And Hydrochlorothiazide vs Sacubitril And Valsartan→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Sacubitril And Valsartan: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Telmisartan And Amlodipine: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Sacubitril And Valsartan vs Telmisartan And Amlodipine

Compare Sacubitril And Valsartan (ARB) and Telmisartan And Amlodipine (Telmisartan and Amlodipine), clinical data, side effects, and patient experiences.

Sacubitril And Valsartan

· ARB

How it works

12.1 Mechanism of Action ENTRESTO contains a neprilysin inhibitor, sacubitril, and an angiotensin receptor blocker, valsartan. ENTRESTO inhibits neprilysin (neutral endopeptidase; ...

Approved for

1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril

a neprilisin inhibitor

and valsartan

an angiotensin II receptor blocker

OralTablet

Telmisartan And Amlodipine

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

Sacubitril And ValsartanTelmisartan And Amlodipine

Drug Class

ARB

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Sacubitril And Valsartan

Low Blood Pressure

>10%

Shortness of Breath

1-10%

Fatigue

1-10%

Cough

1-10%

Weight Loss

1-10%

General Unwellness

0.1-1%

Weight Gain

0.1-1%

Dizziness

1-10%

Telmisartan And Amlodipine

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

Sacubitril And Valsartan

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of angioedema and hypotension
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
However, if there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system, and if the drug is considered lifesaving for the mother, advise a pregnant woman of the potential risk to the fetus [see Use in Specific Populations (8
Angioedema associated with laryngeal edema may be fatal

Telmisartan And Amlodipine

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

Clinical Trial Data

No head-to-head clinical studies found for Sacubitril And Valsartan vs Telmisartan And Amlodipine.

Sacubitril And Valsartan vs Telmisartan And Amlodipine: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Sacubitril And Valsartan: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Telmisartan And Amlodipine: DailyMed label · FAERS adverse events · ClinicalTrials.gov